Antagonistic effects of IL-17 and D-resolvins on endothelial Del-1 expression through a GSK-3β-CEBPβ pathway

Nature Communications

Volumn 6, Issue , 2015, Pages

  Maekawa, Tomoki ^a,b   Hosur, Kavita ^a   Abe, Toshiharu ^a   Kantarci, Alpdogan ^c   Ziogas, Athanasios ^d   Wang, Baomei ^a   Van Dyke, Thomas E ^c   Chavakis, Triantafyllos ^d   Hajishengallis, George ^a  

^a UNIVERSITY OF PENNSYLVANIA SCHOOL OF DENTAL MEDICINE   (United States)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^c FORSYTH INSTITUTE   (United States)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

8 [4 (1 AMINOCYCLOBUTYL)PHENYL] 9 PHENYL 1,2,4 TRIAZOLO[3,4 F][1,6]NAPHTHYRIDIN 3(2H) ONE; CCAAT ENHANCER BINDING PROTEIN BETA; DEL 1 PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; INTERLEUKIN 17; LIPOXIN; LY 249002; LY 303511; OMEGA 3 FATTY ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN; PROTEIN KINASE B; RESOLVIN D1; RESOLVIN D2; UNCLASSIFIED DRUG; CARRIER PROTEIN; CEBPB PROTEIN, HUMAN; CEBPB PROTEIN, MOUSE; DOCOSAHEXAENOIC ACID; EDIL3 PROTEIN, HUMAN; EDIL3 PROTEIN, MOUSE; GLYCOGEN SYNTHASE KINASE 3; GSK3B PROTEIN, HUMAN; GSK3B PROTEIN, MOUSE; PEROXIDASE;

DISEASE TREATMENT; GENE EXPRESSION; HOMINID; NETWORK ANALYSIS; PATHOLOGY; PROTEIN; RODENT;

ALVEOLAR BONE LOSS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL MODEL; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; PERIODONTITIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; ANIMAL; CHROMATIN IMMUNOPRECIPITATION; DISEASE MODEL; DOWN REGULATION; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; GINGIVA; IMMUNOBLOTTING; IMMUNOLOGY; IMMUNOPRECIPITATION; KNOCKOUT MOUSE; METABOLISM; PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL;

MUS;

ALVEOLAR BONE LOSS; ANIMALS; CARRIER PROTEINS; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CHROMATIN IMMUNOPRECIPITATION; DISEASE MODELS, ANIMAL; DOCOSAHEXAENOIC ACIDS; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; GINGIVA; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INTERLEUKIN-17; MICE; MICE, KNOCKOUT; PERIODONTITIS; PEROXIDASE; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 84942053330     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms9272     Document Type: Article

References (49)

1. MacDonald, T. T., Monteleone, I., Fantini, M. C. & Monteleone, G. Regulation of homeostasis and inflammation in the intestine. Gastroenterology 140, 1768-1775 (2011).
2. Chovatiya, R. & Medzhitov, R. Stress, inflammation, and defense of homeostasis. Mol. Cell 54, 281-288 (2014).
3. Choi, E. Y. et al. Del-1, an endogenous leukocyte-endothelial adhesion inhibitor, limits inflammatory cell recruitment. Science 322, 1101-1104 (2008).
4. Eskan, M. A. et al. The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss. Nat. Immunol. 13, 465-473 (2012).
5. Choi, E. Y. et al. Developmental endothelial locus-1 is a homeostatic factor in the central nervous system limiting neuroinflammation and demyelination. Mol. Psychiatry 20, 880-888 (2014).
6. Kanczkowski, W. et al. Role of the endothelial-derived endogenous anti-inflammatory factor Del-1 in inflammation-mediated adrenal gland dysfunction. Endocrinology 154, 1181-1189 (2013).
7. Kang, Y. Y., Kim, D. Y., Lee, S. H. & Choi, E. Y. Deficiency of developmental endothelial locus-1 (Del-1) aggravates bleomycin-induced pulmonary fibrosis in mice. Biochem. Biophys Res. Commun. 445, 369-374 (2014).
8. Mitroulis, I. et al. Developmental endothelial locus-1 attenuates complementdependent phagocytosis through inhibition of Mac-1-integrin. Thromb. Haemost. 111, 781-1006 (2014).
9. Gaffen, S. L., Jain, R., Garg, A. V. & Cua, D. J. The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat. Rev. Immunol. 14, 585-600 (2014).
10. Shen, F. et al. IL-17 receptor signaling inhibits C/EBPbeta by sequential phosphorylation of the regulatory 2 domain. Sci. Signal 2, ra8 (2009).
11. Gaffen, S. L. Structure and signalling in the IL-17 receptor family. Nat. Rev. Immunol. 9, 556-567 (2009).
12. Huppler, A. R. et al. Role of neutrophils in IL-17-dependent immunity to mucosal candidiasis. J. Immunol. 192, 1745-1752 (2014).
13. Serhan, C. N., Chiang, N. & Van Dyke, T. E. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 8, 349-361 (2008).
14. Spite, M., Claria, J. & Serhan, C. N. Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases. Cell Metab. 19, 21-36 (2014).
15. Ortega-Gomez, A., Perretti, M. & Soehnlein, O. Resolution of inflammation: an integrated view. EMBO Mol Med. 5, 661-674 (2013).
16. Hasturk, H., Kantarci, A. & Van Dyke, T. E. Paradigm shift in the pharmacological management of periodontal diseases. Front. Oral Biol 15, 160-176 (2012).
17. Takahashi-Yanaga, F. Activator or inhibitor? GSK-3 as a new drug target. Biochem. Pharmacol. 86, 191-199 (2013).
18. Medina, M. & Wandosell, F. Deconstructing GSK-3: The fine regulation of Its activity. Int. J. Alzheimers Dis. 2011, 479249 (2011).
19. Roy, S. K. et al. A role for mixed lineage kinases in regulating transcription factor CCAAT/enhancer-binding protein-b-dependent gene expression in response to interferon-g. J. Biol. Chem. 280, 24462-24471 (2005).
20. Chen, J. & Ivashkiv, L. B. IFN-g abrogates endotoxin tolerance by facilitating Toll-like receptor-induced chromatin remodeling. Proc. Natl Acad. Sci. USA 107, 19438-19443 (2010).
21. Shin, J. et al. Expression and function of the homeostatic molecule Del-1 in endothelial cells and the periodontal tissue. Clin. Dev. Immunol 2013, 617809 (2013).
22. Descombes, P. & Schibler, U. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 67, 569-579 (1991).
23. Piwien-Pilipuk, G., Van Mater, D., Ross, S. E., MacDougald, O. A. & Schwartz, J. Growth hormone regulates phosphorylation and function of CCAAT/enhancer-binding protein beta by modulating Akt and glycogen synthase kinase-3. J. Biol. Chem 276, 19664-19671 (2001).
24. Ohira, T. et al. Resolvin E1 receptor activation signals phosphorylation and phagocytosis. J. Biol. Chem. 285, 3451-3461 (2010).
25. Odusanwo, O., Chinthamani, S., McCall, A., Duffey, M. E. & Baker, O. J. Resolvin D1 prevents TNF-a -mediated disruption of salivary epithelial formation. Am. J. Physiol. Cell Physiol 302, C1331-C1345 (2012).
26. Martin, M., Rehani, K., Jope, R. S. & Michalek, S. M. Toll-like receptormediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat. Immunol. 6, 777-784 (2005).
27. Krishnamoorthy, S. et al. Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc. Natl Acad. Sci. U S A 107, 1660-1665 (2010).
28. Norling, L. V., Dalli, J., Flower, R. J., Serhan, C. N. & Perretti, M. Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions. Arterioscler. Thromb. Vasc. Biol. 32, 1970-1978 (2012).
29. Abe, T. et al. Local complement-targeted intervention in periodontitis: proof-of-concept using a C5a receptor (CD88) antagonist. J. Immunol. 189, 5442-5448 (2012).
30. Iwakura, Y., Ishigame, H., Saijo, S. & Nakae, S. Functional specialization of interleukin-17 family members. Immunity 34, 149-162 (2011).
31. Sikorski, K. et al. STAT1 as a central mediator of IFNg and TLR4 signal integration in vascular dysfunction. JAKSTAT 1, 241-249 (2012).
32. Tesmer, L. A., Lundy, S. K., Sarkar, S. & Fox, D. A. Th17 cells in human disease. Immunol. Rev. 223, 87-113 (2008).
33. Amadi-Obi, A. et al. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat. Med. 13, 711-718 (2007).
34. Takayanagi, H. et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-g. Nature 408, 600-605 (2000).
35. Miossec, P. & Kolls, J. K. Targeting IL-17 and TH17 cells in chronic inflammation. Nat. Rev. Drug Discov. 11, 763-776 (2012).
36. Serhan, C. N. & Petasis, N. A. Resolvins and protectins in inflammation resolution. Chem. Rev. 111, 5922-5943 (2011).
37. Arnardottir, H. H., Dalli, J., Colas, R. A., Shinohara, M. & Serhan, C. N. Aging delays resolution of acute inflammation in mice: reprogramming the host response with novel nano-proresolving medicines. J. Immunol. 193, 4235-4244 (2014).
38. Hajishengallis, G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat. Rev. Immunol. 15, 30-44 (2015).
39. Colombo, A. P. et al. Impact of periodontal therapy on the subgingival microbiota of severe periodontitis: comparison between good responders and individuals with refractory periodontitis using the human oral microbe identification microarray. J. Periodontol. 83, 1279-1287 (2012).
40. Beikler, T. & Flemmig, T. F. Oral biofilm-associated diseases: trends and implications for quality of life, systemic health and expenditures. Periodontol. 2000 55, 87-103 (2011).
41. Baban, B., Liu, J. Y., Abdelsayed, R. & Mozaffari, M. S. Reciprocal relation between GADD153 and Del-1 in regulation of salivary gland inflammation in Sjogren Syndrome. Exp. Mol. Pathol. 95, 288-297 (2013).
42. Goris, A. et al. New candidate loci for multiple sclerosis susceptibility revealed by a whole genome association screen in a Belgian population. J. Neuroimmunol. 143, 65-69 (2003).
43. Ramanan, V. K. et al. APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study. Mol. Psychiatry 19, 351-357 (2014).
44. Lin, Z. et al. A genome-wide association study in Han Chinese identifies new susceptibility loci for ankylosing spondylitis. Nat. Genet. 44, 73-77 (2012).
45. Dasgupta, S. K., Le, A., Chavakis, T., Rumbaut, R. E. & Thiagarajan, P. Developmental endothelial locus-1 (Del-1) mediates clearance of platelet microparticles by the endothelium. Circulation 125, 1664-1672 (2012).
46. Hajishengallis, G. et al. Differential interactions of fimbriae and lipopolysaccharide from Porphyromonas gingivalis with the Toll-like receptor 2-centred pattern recognition apparatus. Cell. Microbiol. 8, 1557-1570 (2006).
47. Zhong, B. et al. Negative regulation of IL-17-mediated signaling and inflammation by the ubiquitin-specific protease USP25. Nat. Immunol. 13, 1110-1117 (2012).
48. Graves, D. T., Fine, D., Teng, Y. T., Van Dyke, T. E. & Hajishengallis, G. The use of rodent models to investigate host-bacteria interactions related to periodontal diseases. J. Clin. Periodontol. 35, 89-105 (2008).
49. Abe, T. & Hajishengallis, G. Optimization of the ligature-induced periodontitis model in mice. J. Immunol. Methods 394, 49-54 (2013).